Raphael Hans Lwesya is a PhD researcher and science communicator focused on bacteriophages, microbiology, and bioinformatics. He is the founder of The Phage, a platform dedicated to phage research, news, protocols and job opportunities.
Antimicrobial resistance (AMR) is one of the biggest health challenges of our time. Many pathogens that were once easily treated with antibiotics…
When people search “The Phage”, something funny happens: the first result is often a Star Trek storyline about a devastating fictional disease…
If you have cystic fibrosis (CF), you hear the same name again and again: Pseudomonas aeruginosa is a stubborn bacterium that loves…
Inside a honey bee’s gut, an invisible war rages, not between bees and parasites, but between the bacteria that keep the bee…
A few weeks ago, I was chatting with an MSc student who had just isolated her very first phage from a sewage…
Belgian biotech company Vésale Bioscience has officially rebranded as Inteliphage, marking a strategic evolution in its mission and scope. The company, known…
Understanding the difference between enveloped and non-enveloped viruses is key to virology, infection control, and antiviral development. This guide dives deep into…
Scientists from Indiana University Bloomington have published a study that has revealed a fascinating new mechanism by which bacteria can gain a…
The rise of antibiotic resistance has pushed scientists to revisit a century-old idea: using viruses to kill bacteria. Phage therapy once overshadowed…
Indigo Carmine (IC) is a well-known dye used in food, medicine, and scientific research. It’s also called FD&C Blue No. 2 and…
